Table 3.
The advantages and drawbacks of strategies for improving MSC migration.
Strategy | Advantages | Main Drawbacks | Example | Reference |
---|---|---|---|---|
Treatment with cytokine or cytokine cocktail | Simple and fast | Unwanted genes may be expressed, expensive | Pretreat MSCs with flt3 ligand, stem cell factor (SCF) or hepatocyte growth factor (HGF). Pretreat with GSK3β inhibitor | [67,68] |
Hypoxic condition | Simple and fast | Cells probably migrate into non-targeted organs | [72,73] | |
Treatment with compound | Intravenous injection of LLP2A | Unwanted genes may be expressed, expensive | Treatment MSCs Valproate or lithium | [74] |
Genetic modification of MSCs | More directed | Difficult, expensive and risk of tumorigenicity | Overexpression of CXCR4 and integrin β4 | [77,78] |
Genetic modification of injury tissue | Targeted | Immunogenicity, Retroviral-mediated insertional mutagenesis | Transfection of SDF-1 plasmid to injury tissue | [84] |
Injection of ectopic chemokine expressing cells | High efficiency | Safety problems, difficult and expensive | Injection of SDF-1α overexpression MSCs into tissue | [85] |
Introduce certain protein expression | No damage for cell viability and function | Safety problems, Difficult and expensive, Risk of tumorigenicity, | Express SLEX on MSCs membrane | [89] |
Coating of cell surface with antibodies | More targeted | Difficult and expensive | Bind VCAM-1 antibodies to MSCs bone surface | [90] |